In SSc, hypermethylation of the SFRP1 promoter leads to reduced expression in fibroblasts and peripheral blood mononuclear cells, resulting in overactivated Wnt signaling and exacerbating fibrosis. The gene discussed is SFRP1; the disease is systemic sclerosis.